MELT PHARMACEUTICALS
Live / Registered — Registered (as of 31 Dec 2024)
What this means for you
Registered since 31 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97979229
- Registration number
- 7635443
- Mark type
- Stylized text
- Filed
- 30 Sept 2022
- Published for opposition
- 18 Jul 2023
- Registered
- 31 Dec 2024
- Attorney of record
- Laila S. Wolfgram
Goods and services
- Class 042 — Scientific and technological services: Research and development of medications; Research and development of medications for preoperative use; Research and development of pharmaceutical compositions for administration prior to, during, or after a surgical procedure for conscious sedation
Owner
- HARROW IP, LLC, NASHVILLE, TN, US
- Melt Pharmaceuticals, Inc., Nashville, TN, US
- Melt Pharmaceuticals, Inc., Nashville, TN, US
- Melt Pharmaceuticals, Inc., Nashville, TN, US
Prosecution history
- 18 Mar 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 31 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 11 Dec 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Dec 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Nov 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Sept 2024 — USE AMENDMENT FILED
- 20 Nov 2024 — DIVISIONAL PROCESSING COMPLETE
- 11 Sept 2024 — DIVISIONAL REQUEST RECEIVED
- 12 Nov 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Sept 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 11 Sept 2024 — TEAS STATEMENT OF USE RECEIVED
- 13 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2024 — SOU EXTENSION 1 GRANTED
- 12 Feb 2024 — SOU EXTENSION 1 FILED